Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$37.5K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| Open the original filing on SEC.gov |
| Apr 2 | CHRO | Channel Therapeutics Corp | SSELL◷ | 377 | $21.36 | $8.1K | -1.5% | Open the original filing on SEC.gov |
| Apr 2 | CHRO | Channel Therapeutics Corp | SSELL◷ | 420 | $20.52 | $8.6K | -1.7% | Open the original filing on SEC.gov |
| Mar 2 | AUPH | Aurinia Pharmaceuticals… | FTAX | 100,890 | $14.21 | $1.4M | -5.2% | Open the original filing on SEC.gov |
| Feb 27 | AUPH | Aurinia Pharmaceuticals… | AGRANT◆ | 328,424 | — | — | — | Open the original filing on SEC.gov |
| Feb 27 | AUPH | Aurinia Pharmaceuticals… | AGRANT | 196,403 | — | — | +11.3% | Open the original filing on SEC.gov |
| Feb 20 | AUPH | Aurinia Pharmaceuticals… | FTAX | 100,171 | $14.40 | $1.4M | -5.4% | Open the original filing on SEC.gov |
| Jan 2 | AUPH | Aurinia Pharmaceuticals… | FTAX | 113,169 | $15.95 | $1.8M | -5.8% | Open the original filing on SEC.gov |
| Jan 2 | AUPH | Aurinia Pharmaceuticals… | AGRANT | 165,384 | — | — | +9.2% | Open the original filing on SEC.gov |
| Jul 2, 2025 | CHRO | Channel Therapeutics Corp | AGRANT↺ | 25,478 | — | — | — | Open the original filing on SEC.gov |